In general DM, this often presents as non-alcoholic fatty liver disease (NAFLD), defined by excessive hepatic fat accumulation, oxidative stress, and chronic inflammation mediated by cytokines and the NLRP3 inflammasome, potentially progressing to fibrosis and cirrhosis. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.